• Breast Implant Claims Against Manufacturers

  • Breast Implant Deficiency Notices

  • Breast Implant History

  • Breast Implant Lawyers Can Help

  • Breast Implant Social Workers

  • Breast Implant History

  • The Manufacturers

Breast Implant Blog

  • Dow Corning Breast Implant Litigation Lawyers: Breast Implant Lawyers Accepting Dow Corning Breast Implant ClaimsOur Breat Implant lawyers are reviewing Dow Corning Breast Implant Claims for women implanted with Dow Corning implants prior to June ...

Stories and Sharing

  • Dow Corning Breast Implant Litigation Resources: The Claimants’ Advisory Committee (CAC) is the official committee appointed by the U.S. District Court in the Eastern District of Michigian to represent the interests of women in the Dow Corning Bankr...

Breast Implant News

  • Dow Corning Breast Implant Litigation Resources: The Claimants’ Advisory Committee (CAC) is the official committee appointed by the U.S. District Court in the Eastern District of Michigian to represent the interests of women in the Dow Corning Bankr...

Posts Tagged ‘Palm Springs’

Dow Corning Breast Implant Litigation Lawyers

Written by lisaspitzer on . Posted in Breast Implant Blog, Breast Implant News, Dow Corning Breast Implant Stories and Sharing, Silicone Poisoning and Silicone Breast Implants

Breast Implant Lawyers Accepting Dow Corning Breast Implant ClaimsOur Breat Implant lawyers are reviewing Dow Corning Breast Implant Claims for women implanted with Dow Corning implants prior to June 1, 1993 and who are registered with the SF-DCT.

We are here to help with your Dow Corning silicone breast implant claims and will connect you with  a female silicone breast Implant lawyer who has been  helping women for 2 decades.  Our lawyers have  helped women obtain settlements for breast implant diseases such as Lupus, Scleroderma and General Connective Tissue Diseases.

DECEMBER 3, 2015

The District Court issued an Order approving the Consent Order To Establish Guidelines for Distributions From The Class 7 Silicone Material Claimants’ Fund. This means that the Court has authorized approved disease claims in Class 7 to be paid and has approved the parties’ agreed interpretation of “marshaling.” The order will become final once the 30-day time period for appeals has expired and no appeals have been filed. Payments can begin once the Order is final. This means that payments will not begin until sometime in January 2016 or thereafter.

 

DECEMBER 1, 2015

Copy of the SFDCT letter sent to claimaints with an approved Disease Option 2 claim regarding Increased Severity – Please note the deadline date of June 2, 2019 is incorrect. The correct deadline date is June 3, 2019. To read the response, click here.

SEPTEMBER 15, 2015

Omnibus Response to Objections & Submissions Responding to Consent Order to Establish Guidelines for Distribution From Class 7 Silicone Materials Claimants Fund. To read the response, click here.

JULY 29, 2015

Scheduling Order Regarding Consent Order to Establish Guidelines for Distributions from Class 7 Silicone Material Claimants’ Fund. To read the order, click here.

JULY 17, 2015ATTORNEYS:

Wells Fargo, the paying agent for the SF-DCT, requires law firms to provide an updated w-9 before payment can be issued. You can download a copy of the updated w-9 form here. Please complete and return the w-9 to the SF-DCT.

JUNE 12, 2015

Copy of the Notice to Class 7 Claimants Establishing Guidelines mailed by the SFDCT. To read the notice, click here.

JUNE 2, 2015

Judge Hood as issued an Order Authorizing Distribution of the Notice in reference to the Class 7 Consent Order. To read the order, click here.

MAY 26, 2015

CAC FILES MOTION ASKING FOR APPROVAL TO PAY CLASS 7 CLAIMS AND TO RESOLVE THE DISPUTE CONCERNING PREVIOUSLY DENIED “MARSHALING” CLAIMS

On Friday, May 22, 2015, the CAC filed a proposed Consent Order asking the Court to authorize payment of disease claims for Class 7 claimants. Most claimants in Class 7 have been previously paid a $600 Expedited Release Payment, a Foreign Gel Claimant Payment, or a $3,000 Cash-Out Offer. Claimants that rejected the Cash-Out Offer and elected for a full disease review have been waiting for payment on their approved disease claim. With the filing of the motion, the CAC hopes that these claimants can now be paid once the Consent Order is entered by the Court.

In addition, the CAC has reached an agreement with Dow Corning regarding thousands of Class 7 claims that were previously denied by the SF-DCT on the grounds that the claimant allegedly had not “marshaled” their recoveries from their primary manufacturer (Bristol, Baxter). Under this agreement, claims will be reviewed to determine if the claimant was eligible to apply for disease compensation from the Revised Settlement Program. If so, then that claimant cannot apply for the same disease in Class 7. However, if a claimant was not eligible to receive benefits for a particular disease in the RSP, then that claimant may seek compensation from Class 7.

For example, if a claimant was an Other Registrant in the RSP, the only disease option she was eligible for was Disease Option 2 (called Long Term Benefits). Other Registrants were not eligible for Disease Option 1 (Fixed Benefits) and diseases like ACTD. These claimants may now seek compensation for Disease Option 1 from Class 7.

The SF-DCT will re-review the claims that were previously denied and will send eligible claimants either a $600 Expedited Release Payment or $3,000 Cash-Out Payment. The Cash-Out Payment is available only to those claimants who submitted a disease claim in 2006. Claimants may reject the Cash-Out Payment and instead elect for a full disease review; however, if the claim is not approved, they will not be eligible for the Cash-Out Offer again.

 

MAY 4, 2015

The MDL Common Benefit Trust fund has announced that it will offer women who were not compensated for Explantation in either the MDL or Dow Corning Settlement a chance to apply for $5,000 explant payment. For more information about this program, please click here. Please note that this program is not affiliated with either the RSP or Dow Corning Settlement Plan.

If you are having difficulty getting your medical insurance to cover the cost of the explant surgery, there is a new resource for women. The Insurance Coverage Assistance Program will be available to provide advice and assistance on how to assess this Medicare, Medicaid, and health care coverage for issues related to breast implants. This program is to be operated by the National Center for Health Research, a consumer-oriented non-profit group in Washington, D.C., that has helped women seek insurance coverage for breast implant removal. The National Center currently operates the breastimplantinfo.org website. You may email them at info@breastimplantinfo.org with your name and email address for more information, including their toll-free number. If you do not have access to email, you can call them at 202-223-4000.

FEBRUARY 10, 2015

On January 27, 2015, the Court of Appeals reversed the District Court’s authorization to make 50% partial Premium Payments. Fortunately, the SF-DCT has already made 98% of the partial Premium Payments to eligible, approved claimants. This money does not need to be repaid. Claimants can keep the partial Premium Payment checks that were issued to them. Unfortunately, the remaining 2% of claimants who did not receive their partial Premium Payment check (or returned it for reissuance, or who had lost checks) are on hold pending either a consensual resolution to pay their claims or a court order. A copy of the ruling is under the tab “Court Orders.”

February 10, 2015,

CAC filed a petition for rehearing on this ruling, asking the Court of Appeals to reconsider or rehear the issue based on what the CAC believes are two serious legal errors. A copy of the petition is under the tab “Appeals to the 6th Circuit” and then under the sub-tab “Premium Payments.”

IF YOU NEED HELP WITH YOUR DOW CORNING BREAST IMPLANT CLAIM CONTACT US TODAY

 

New Silicone Breast Implant Approved

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

Breast Implant Helpline keeps you updated on all breast implant news. Years after the Dow Corning Silicone Breast Implant disaster a new silicone breast implant hits the market. The FDA has  approved a  new silicone gel breast implant from Johnson & Johnson.

 Next Generation breast Implant?

The Food and Drug Administration said it has  approved a next-generation silicone breast implant from Mentor, a unit of New Brunswick-based Johnson & Johnson. Ladies let’s remember who this is. The same folks that bring you the vaginal mesh implant that is ruing lives nationwide. We watch with skepticism. The company’s MemoryShape breast implant uses a cross-linking gel design that the FDA says is firmer than previous implants. FDA regulators approved the new implant for breast enhancement and reconstruction in women at least 22 years old.

Can Silicone Breast Implants Make A Comeback?

Silicone gel implants have made a comeback recently after safety concerns kept them off the market for nearly 25 years.

The FDA banned sales of silicone breast implants in 1992, saying manufacturers had not provided enough medical data showing their safety and effectiveness. At the time, there were worries about a connection to a variety of diseases, including cancer and lupus. Alarming cases of ruptures added to the concern. Women are still waiting on settlements from the Dow Corning Class Actions and a new breast implant explant program has been announced.

An Overview

The FDA said Friday it approved Mentor’s new implant based on studies tracking six years of data in 955 women. The agency said complications with Mentor’s MemoryShape implants were similar to those from previously approved silicone gel implants.

 New Requirements

FDA is requiring Mentor to meet a number of requirements in connection with the new approval, including:

• Tracking the 955 women with the new implant

• Conducting a new study of 2,500 women who receive the new implant

• Evaluating women’s comprehension and perception of the implant’s labeling

• Analyzing any implants that are removed from women and returned to the manufacturer

More than one in five women who get implants for breast enhancement will need to have them replaced within five years, accord to an FDA analysis of company data released in 2011. Despite that relatively high failure rate, FDA regulators concluded that the silicone-gel implants are basically safe, as long as women understand they come with complications. Some critics of the implants say the failure rate may be even higher, since many women have dropped out of the company studies.

We will be watching.

Dow Corning Breast Implant Explant Program, Breast Implant Lawyers

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

You may have received a letter from the Dow Corning Trust explaining a Breast Implant explant program. For help in understanding your rights and to speak to a breast implant explant lawyer contact the Breast Implant Helpline today

There is a Breast Implant Explant Program Deadline

The final deadline to submit an Explant Claim to the SF-DCT is June 2, 2014. You must have acceptable Proof of Manufacturer before you can be considered for the Explant benefit. The Explant benefit is $5,000.00. To qualify for this benefit, you must have your Dow Corning implants removed and not replaced with silicone.

It can take six months or longer to schedule an explant surgery and to obtain the necessary medical records from your surgeon or hospital.  If you are eligible  to apply for this benefit, you should keep this deadline date in mind. Do not  wait  to discuss your  explant surgery with your doctor. This should be done as soon as possible.

What Is Breast Implant  Explant Surgery?

Breast explant surgery  is mplant removal. Explant surgery is the process by which your breast implants are removed from the breasts. Depending upon the reason for the surgery, additional material may be removed.

Dow Corning Explant Benefits Notice

EXPLANT DEADLINE IS JUNE 2, 2014

The Settlement Facility will mail letters to Class 5 and 6 claimants on April 26, 2013 reminding them of the Explant Deadline of June 2, 2014.

What is the Explant Deadline? To be eligible for the $5,000 Explant benefit (Class 5 only), you must have your Dow Corning breast implant removed by June 2, 2014 and you cannot receive another silicone gel breast implant after that. To file a claim, you must submit the Explant Form and the operative statement from the Explant surgery. Only claimants in Class 5 and 6.1 (non-U.S. Dow Corning breast implant claimants) are eligible for the Explant Payment.

June 2, 2014 may seem like a long time away, but our experience has been that it often takes up to 6 months or more to schedule an appointment with your surgeon, schedule the surgery, and obtain the necessary medical reports (such as the Operative Report) to submit a claim by the deadline.

If your Dow Corning breast implant is not removed by June 2, 2014, then you cannot apply for the Explant benefit.There is still money available to help you remove your defective Dow implants. There is money available to help you remove your defective breast implants

 

Drugs and Devices Harming Women, VaginaL Mesh, Mirena IUD, And Others

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing, Drugs and Devices Harming Women

There have been so many drugs and devices targeting women over the years with so many ending up in FDA warnings, recalls and resulting in lawyers in the courtroom arguing for justice for 1000's of injured women. To name a few; equal and maybe far surpassing the Dow Corning Breast implant Class Action is the Prolene vaginal mesh. This device, used by OB GYN's for urinary incotinence and  uterine, bladder and bowel prolapse, has been falling apart in women. The result has been pain suffering and  the destruction of lives and marriages.

The failing mesh can erode thru the vaginal wall or even into the bladder or bowel, The pain is relentless and infections are ongoing. Many women are having a difficult time finding sympathetic doctors to remove the mesh as urinary incotinence returns and re prolapse occurr.

Two others are both manufactured by Bayer Pharmaceuticals. Yaz birth control pills has warnings for blood clots in young women, strokes, pulmonary embolisms and deep vein thrombosis. The latest is the popular Mirena IUD.  The Mirena can stay inplanted for up to five years but  can gravitate or migrate and cause uterine and abdomen perforations. The stories of lives ruined goes on and on. Even the metat on metal hip replacements like the recalled DePuy and Stryker are more detrimental to women sdue to the smaller frames.

Every day we hear about more  dangerous drugs and medical devices. Our T.V's are filled with lawyer ads seeking injured women. These products like Fosamax, birth control medications and uterine devices; the transvaginal mesh and metal-on-metal hip implants all focus on women as their market. Eventually these products  end up with warnings, are recalled and are consolidated in a multi-district litigation to defend 1000's of harmed women. In some cases they are fatal.

These products we see lawyer ds for include: Yaz, Transvaginal Mesh, Mirena IUD, Fosamax, DePuy Hip Replacement  and others  are flashing cross our T.V screens " have you been injured by" "Call th law firm of….." We encourage women to file their lawsuits, not necessarily with the lawyer they see on T.V but with a qualified experienced class action lawsuit lawyer who understands the MDL process and has experience in these matters. Be sure the lawyer you choose is not just taking your case to get his piece off the top and sending it to a"buddy".

The Breast Implant Helpline's new mission is to help all women find justice against manufacturer who choose profits over  accurate warnings, and direct you to a dangerous drugs and devices lawyer for women.

 

 

California Breast Implant Lawyers, Women Implanted Before !995

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

and registered with Dow Corning or one of the other settlerment facilities we are here to help you get your full compensation. We can help with MDL-926 and SFDCT claims, Disease proof, deficiency notices anddisease claims as well as proof of manufacturer. In California we can help you in: Bakersfield, CA; Chico, CA; Fresno, CA; Humboldt County, CA; Inland Empire, CA; Long Beach, CA; Los Angeles, CA; Mendocino ,( CA; Merced, CA; Modesto, CA; Monterey, CA; O.C. CA.; Oakland, CA; Palm Springs, CA; Palmdale, CA; Redding, CA; Sacramento, CA; San Diego, CA; San Fernando Valley, CA; San Francisco, CA; San Gabriel Valley, CA; San Jose CA;, San Luis Obispo , CA; ,San Mateo, CA; ,Santa Barbara, CA; Santa Cruz ,CA; Santa Maria, CA; Siskiyou, CA; Stockton, CA; Susanville, CA; Ventura, CA; Visalia ,CA;

Call The Breast  Implant  Helpline California and Speak to a female medical social worker and  a female silicone breast implant lawyer

About Silicone Breast Implants
There are two types of breast implants. Silicone gel-filled breast implants have a silicone outer shell that is filled with silicone gel. Saline filled breast implants contain a silicone outer shell filled with a sterile saltwater (saline) solution.
Both types of implants have had adverse affects to the human immune system.implants   Any amount of silicone, no matter how small, can cause your body to have an internal allergic reaction or toxicity disease. Medical Studies have shown that there is probably nothing that you can place in the human body that the body will not attempt to break down. Silicone implants in the body are broken down over time through a lipolysis reaction. Most silicone-filled breast implants leak or rupture within 8 to 15 years.

Manufacturers of Silicone Breast Implants

  • Mentor,
  • Dow Corning
  • Baxter;
  • Bristol Myer Squibb
  • Heyer-Schulte;
  • Surgitek;
  • Mentor;
  • CUI;
  • Cox-Uphoff;
  • 3M,
  • McGhan,
  • Bioplasty

Complications of Silicone Breast Implants

  • Lupus,
  • autoimmune disease,
  • dry eyes,
  • dry mouth
  •  joint pain with swelling
  •  skin rashes,
  • face rashes,
  • numbness and tingling in hands and toes,
  • chronic fatigue,
  • fibromyalgia,
  • muscle pain,
  • abnormal blood work

women who had received breast implants should notify their doctors of any changes in their breasts because of a possible association with a rare type of lymphoma. In breast implant patients, ALCL has occurred in the scar capsule adjacent to the implant.

Symptoms of breast implant lymphoma include:

  •     Pain
  •     Lumps
  •     Swelling
  •     Asymmetry that developed after their initial surgical sites were fully healed

The myths and controversy of Silicone Breast Implants
Breast Implants were introduced onto the market in 1970’s, women were told their implants would last forever. For someone who had under gone mastectomies due to Breast Cancer, they were getting a new lease in life; they had a chance to feel like a woman again. Others, whose breast unfortunately never fully matured, felt they finally had a chance to love their bodies and figure. Everyone was under the impression that these implants were indestructible and there would never be any complications. Unfortunately, we were all misled.
Problems relating to breast implants began to surface in the late 1980’s. They were finally removed from the market by the FDA in 1992.New studies have proven that Breast Implants are not lifetime devices. The longer you have breast implants, the more likely it is that complications will occur. Even though the FDA has made these claims, many physicians still do not believe there is any connection to autoimmune disease and Breast Implants. To this day, most women had no idea that their sicknesses and diseases could have been related to their silicone implants.
Settlement Facility Dow Corning Trust:

YOU CAN STILL FILE A CLAIM WITHIN THE DOW SETTLEMENT
Many women registered with the SF-DCT prior to their bankruptcy. Compensation is still available for explant (implant removal) and disease claims.

Call the breast Implant Helpline. Speak to a femal medical social worker and female attorney  to learn about your status

  MDL-926 Breast Implant claims

If you are a registered claimant in the MDL 926, and have received a deficiency notice, call or email our office today to give us an opportunity to examine the Claims Offices' ruling.

There are many different types of disease that fall under the guidelines of the Class Action. Different levels of compensation are available for specific disease and diagnoses’. Some of them are: Lupus, autoimmune disease, dry eyes, dry mouth; joint pain with swelling, skin rashes, face rashes, numbness and tingling in hands and toes (neuropathy), chronic fatigue, muscle pain, or abnormal blood work. If you have any of these symptoms, you may be entitled to compensation.
How can a lawyer help me?
The Breast Implant Litigation has many different categories. Many years of deadlines and false promises have made this Class Action very confusing. You deserve the right to justice and compensation if you meet the criteria. Call the Breast Implant Helpline, Alabama today

 

California Breast Implant Lawyers look at a New Breast Implant

Written by lisaspitzer on . Posted in Dow Corning Breast Implant Stories and Sharing

Breast Implant helpline is helping women in California who are victims of the Dow Corning Breast Implants with claims, deficiency notices and disease status. Now a new breast Implant has been approved and our Breast implant Helpline Lawyers are watching and wondering. Allergan and Mentor were part of the original silicone breast Implant disaster that left women with deformity and toxicity diseases Helping women with filed claims in Breast Implant  claims in Bakersfield, Chico, Fresno, Long beach, Los Angeles, Mendocino, Merced, Modesto, Monterery, North Bay, Palm Springs, Palmdale, Sacramento, San fransisco, San Jose, San Luis Osbispo, San Mateo, Santa Barbara, Santa Cruz, Santa Maria, Siskiyou, Stockton, Susanville, Ventura, Visalia and all of California.

If you received Breast implants between 1965-June 1,1993, you may be eligible to participate in the Dow Corning and/or MDL 926 class actions

New Silicone Breast Implant Approved
The third such implant sanctioned in the U.S.
March 9, 2012 RSS Feed Print

FRIDAY, March 9 (HealthDay News) — Sientra Inc.'s silicone gel-filled breast implant has been approved by the U.S. Food and Drug Administration for breast reconstruction or augmentation in women aged 22 or older, the agency said Friday in a news release.

Similar products made by two other manufacturers — Allergan and Mentor –– were approved previously by the FDA.

Breast reconstruction includes replacing tissue removed due to cancer or injury, while augmentation generally is used to increase breast size.

Approval of the Sientra product followed clinical testing involving 1,788 people. Adverse reactions included tightening of the area surrounding the implant, implant removal, uneven appearance and infection.

As a condition of approval, Sientra will be required to follow clinical participants for seven additional years, and to conduct a 10-year study of nearly 5,000 women to see if the implants are associated with diseases including rheumatoid arthritis and breast cancer.

Sientra is based in Santa Barbara, Calif.

We hope the new Breast Implants will be monitored successfully and  right for women. The Breast Implant Helpline is here to help